.png)
Olivier Elemento, Ph.D.
Is the Director of the Englander Institute for Precision Medicine, Professor in the Department of Physiology and Biophysics, Associate Director of the Institute for Computational Biomedicine, and Associate Program Director of the Clinical & Translational Science Center at Weill Cornell Medicine.
Dr. Elemento is a world-renowned computational biologist who led the development the first New York State-approved whole exome sequencing test for oncology and also developed new methods for assessing tumor-driving pathways, the immune landscape of tumors and predicting immunotherapy responders. Moreover, Dr. Elemento developed methodologies to repurpose existing drugs to target specific pathways, predict drug toxicity and identify synergistic drug combinations combining Big Data with experimentation and genomic profiling to accelerate the discovery of cancer cures. Dr. Elemento has published over 150 scientific papers in the area of genomics, epigenomics, computational biology and drug discovery.
